[HTML][HTML] Risk for hepatitis b virus reactivation in patients with psoriasis treated with biological agents: A systematic review and meta-analysis
X Wang, M Zhang, Y Chen, Y Liu, Y Yu, X Huang… - Dermatology and …, 2022 - Springer
Introduction Notwithstanding their numerous advantages, biological treatments have many
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
[HTML][HTML] Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis
X Wang, M Zhang, Y Chen, Y Liu, Y Yu… - Dermatology and …, 2022 - ncbi.nlm.nih.gov
Methods In accordance with the PRISMA guidelines, we systematically searched Pubmed,
Scopus, Embase, Cochrane Library, and Web of Science databases for observational …
Scopus, Embase, Cochrane Library, and Web of Science databases for observational …
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis
X Wang, M Zhang, Y Chen, Y Liu… - Dermatology and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Notwithstanding their numerous advantages, biological treatments have many
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis.
X Wang, M Zhang, Y Chen, Y Liu, Y Yu… - Dermatology and …, 2022 - europepmc.org
Methods In accordance with the PRISMA guidelines, we systematically searched Pubmed,
Scopus, Embase, Cochrane Library, and Web of Science databases for observational …
Scopus, Embase, Cochrane Library, and Web of Science databases for observational …
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis.
X Wang, M Zhang, Y Chen, Y Liu, Y Yu… - Dermatology & …, 2022 - search.ebscohost.com
Introduction: Notwithstanding their numerous advantages, biological treatments have many
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis.
X Wang, M Zhang, Y Chen, Y Liu, Y Yu… - Dermatology and …, 2022 - go.gale.com
Introduction Notwithstanding their numerous advantages, biological treatments have many
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …
limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need …